Ausgabe 11/2015
Inhalt (8 Artikel)
Commentary
How to Improve the Safe and Effective Use of Doxorubicin in Children with Cancer
John N. van den Anker
Review Article
Pharmacokinetics-Based Approaches for Bioequivalence Evaluation of Topical Dermatological Drug Products
Sam G. Raney, Thomas J. Franz, Paul A. Lehman, Robert Lionberger, Mei-Ling Chen
Review Article
Clinical Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Approved to Treat Rheumatoid Arthritis
David Ternant, Theodora Bejan-Angoulvant, Christophe Passot, Denis Mulleman, Gilles Paintaud
Open Access
Review Article
Ticagrelor: Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Profile: An Update
Renli Teng
Original Research Article
Age-Dependent Pharmacokinetics of Doxorubicin in Children with Cancer
Swantje Völler, Joachim Boos, Miriam Krischke, Gudrun Würthwein, Nina E. Kontny, Alan V. Boddy, Georg Hempel
Original Research Article
Investigation of Saliva as an Alternative to Plasma Monitoring of Voriconazole
Kim Vanstraelen, Johan Maertens, Patrick Augustijns, Katrien Lagrou, Henriette de Loor, Raf Mols, Pieter Annaert, Anne Malfroot, Isabel Spriet
Original Research Article
The Impact of Sertraline Co-Administration on the Pharmacokinetics of Olanzapine: A Population Pharmacokinetic Analysis of the STOP-PD
Simon J. C. Davies, Benoit H. Mulsant, Alastair J. Flint, Barnett S. Meyers, Anthony J. Rothschild, Ellen M. Whyte, Margaret M. Kirshner, Denise Sorisio, Bruce G. Pollock, Robert R. Bies
Original Research Article
Prediction of Fat-Free Mass in Children
Hesham Saleh Al-Sallami, Ailsa Goulding, Andrea Grant, Rachael Taylor, Nicholas Holford, Stephen Brent Duffull